{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:49:24Z","timestamp":1775486964572,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/NEU\/04539\/2013"],"award-info":[{"award-number":["UID\/NEU\/04539\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/SAU-MET\/121133\/2010"],"award-info":[{"award-number":["PTDC\/SAU-MET\/121133\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-017-3877-1","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T07:33:37Z","timestamp":1515051217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":207,"title":["Using Resistin, glucose, age and BMI to predict the presence of breast cancer"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4671-3703","authenticated-orcid":false,"given":"Miguel","family":"Patr\u00edcio","sequence":"first","affiliation":[]},{"given":"Jos\u00e9","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Cris\u00f3stomo","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Matafome","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Sei\u00e7a","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Caramelo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,1,4]]},"reference":[{"key":"3877_CR1","doi-asserted-by":"crossref","unstructured":"Cris\u00f3stomo J, et al. Hyperresistinemia and metabolic dysregulation: the close crosstalk in obese breast cancer. Endocrine. 2016;53(2):433-42.","DOI":"10.1007\/s12020-016-0893-x"},{"issue":"1\u20132","key":"3877_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/prca.201200075","volume":"7","author":"KD Cole","year":"2013","unstructured":"Cole KD, He HJ, Wang L. Breast cancer biomarker measurements and standards. Proteomics Clin Appl. 2013;7(1\u20132):17\u201329.","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"3877_CR3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2753.2007.00849.x","volume":"14","author":"HL Hwa","year":"2008","unstructured":"Hwa HL, et al. Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models. J Eval Clin Pract. 2008;14(2):275\u201380.","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"3877_CR4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jcla.21555","volume":"27","author":"JG Santillan-Benitez","year":"2013","unstructured":"Santillan-Benitez JG, et al. The tetrad BMI, Leptin, Leptin\/Adiponectin (L\/a) ratio and CA 15-3 are reliable biomarkers of breast cancer. J Clin Lab Anal. 2013;27(1):12\u201320.","journal-title":"J Clin Lab Anal"},{"issue":"7\u20138","key":"3877_CR5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.clinbiochem.2013.01.001","volume":"46","author":"M Dalamaga","year":"2013","unstructured":"Dalamaga M, et al. Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters. Clin Biochem. 2013;46(7\u20138):584\u201390.","journal-title":"Clin Biochem"},{"key":"3877_CR6","doi-asserted-by":"crossref","unstructured":"Assiri AM, Kamel HF. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer. Obes Res Clin Pract. 2015;10(4):442-53.","DOI":"10.1016\/j.orcp.2015.08.017"},{"key":"3877_CR7","volume-title":"Comment on \"evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and vistafin in postmenopausal breast cancer\"","author":"M Patr\u00edcio","year":"2016","unstructured":"Patr\u00edcio, M. and F. Caramelo, Comment on \"evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and vistafin in postmenopausal breast cancer\". Obesity Research & Clinical Practice, 2016."},{"issue":"1","key":"3877_CR8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1186\/s12885-015-1898-1","volume":"15","author":"X Provatopoulou","year":"2015","unstructured":"Provatopoulou X, et al. Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics. BMC Cancer. 2015;15(1):898.","journal-title":"BMC Cancer"},{"key":"3877_CR9","doi-asserted-by":"crossref","unstructured":"Witten, I.H., E. Frank, and M.A. Hall, Data Mining: Practical Machine Learning Tools and Techniques. 3rd ed. Morgan Kaufmann; 2011.","DOI":"10.1016\/B978-0-12-374856-0.00001-8"},{"issue":"1","key":"3877_CR10","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/bcr3375","volume":"15","author":"V Kloten","year":"2013","unstructured":"Kloten V, et al. Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening. Breast Cancer Res. 2013;15(1):R4.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"3877_CR11","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.3390\/ijms131013587","volume":"13","author":"AW Opstal-van Winden","year":"2012","unstructured":"Opstal-van Winden AW, et al. A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum. Int J Mol Sci. 2012;13(10):13587\u2013604.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3877_CR12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s13058-014-0456-0","volume":"16","author":"Q Zhu","year":"2014","unstructured":"Zhu Q, et al. Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near-infrared imaging parameters and tumor pathologic criteria. Breast Cancer Res. 2014;16(5):456.","journal-title":"Breast Cancer Res"},{"issue":"22","key":"3877_CR13","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/jnci\/djm224","volume":"99","author":"RT Chlebowski","year":"2007","unstructured":"Chlebowski RT, et al. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst. 2007;99(22):1695\u2013705.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"3877_CR14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111\u201330.","journal-title":"Stat Med"},{"issue":"7","key":"3877_CR15","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1007\/s13277-015-3567-z","volume":"36","author":"G Khakpour","year":"2015","unstructured":"Khakpour G, et al. DNA methylation as a promising landscape: a simple blood test for breast cancer prediction. Tumour Biol. 2015;36(7):4905\u201312.","journal-title":"Tumour Biol"},{"issue":"4","key":"3877_CR16","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.eswa.2013.08.044","volume":"41","author":"BC Zheng","year":"2014","unstructured":"Zheng BC, Yoon SW, Lam SS. Breast cancer diagnosis based on feature extraction using a hybrid of K-means and support vector machine algorithms. Expert Syst Appl. 2014;41(4):1476\u201382.","journal-title":"Expert Syst Appl"},{"issue":"1","key":"3877_CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10489-007-0073-z","volume":"30","author":"I Maglogiannis","year":"2009","unstructured":"Maglogiannis I, Zafiropoulos E, Anagnostopoulos I. An intelligent system for automated breast cancer diagnosis and prognosis using SVM based classifiers. Appl Intell. 2009;30(1):24\u201336.","journal-title":"Appl Intell"},{"key":"3877_CR18","doi-asserted-by":"crossref","unstructured":"Ali\u010dkovi\u0107 E, Subasi A. Breast cancer diagnosis using GA feature selection and rotation Forest. Neural Comput & Applic. 2017;28(4):753\u201363.","DOI":"10.1007\/s00521-015-2103-9"},{"issue":"23","key":"3877_CR19","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1073\/pnas.87.23.9193","volume":"87","author":"WH Wolberg","year":"1990","unstructured":"Wolberg WH, Mangasarian OL. Multisurface method of pattern separation for medical diagnosis applied to breast cytology. Proc Natl Acad Sci U S A. 1990;87(23):9193\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3877_CR20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96(5):644\u20137.","journal-title":"Acta Paediatr"},{"issue":"1","key":"3877_CR21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32\u20135.","journal-title":"Cancer"},{"key":"3877_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2014.03.039","volume":"829","author":"PS Gromski","year":"2014","unstructured":"Gromski PS, et al. A comparative investigation of modern feature selection and classification approaches for the analysis of mass spectrometry data. Anal Chim Acta. 2014;829:1\u20138.","journal-title":"Anal Chim Acta"},{"issue":"1","key":"3877_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-7439(00)00122-2","volume":"56","author":"QS Xu","year":"2001","unstructured":"Xu QS, Liang YZ. Monte Carlo cross validation. Chemom Intell Lab Syst. 2001;56(1):1\u201311.","journal-title":"Chemom Intell Lab Syst"},{"issue":"9458","key":"3877_CR24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0140-6736(05)17866-0","volume":"365","author":"S Michiels","year":"2005","unstructured":"Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet. 2005;365(9458):488\u201392.","journal-title":"Lancet"},{"key":"3877_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2288-14-137","volume":"14","author":"T van der Ploeg","year":"2014","unstructured":"van der Ploeg T, Austin PC, Steyerberg EW. Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints. BMC Med Res Methodol. 2014;14:137.","journal-title":"BMC Med Res Methodol"},{"key":"3877_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJMoa052911","volume":"353","author":"ED Pisano","year":"2005","unstructured":"Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:17.","journal-title":"N Engl J Med"},{"issue":"29","key":"3877_CR27","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","volume":"35","author":"EW Steyerberg","year":"2014","unstructured":"Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014;35(29):1925\u201331.","journal-title":"Eur Heart J"},{"issue":"15","key":"3877_CR28","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2015.11766","volume":"314","author":"J Jin","year":"2015","unstructured":"Jin J. Breast cancer screening guidelines in the United States. JAMA. 2015;314(15):1658.","journal-title":"JAMA"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3877-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T21:05:32Z","timestamp":1570568732000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3877-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3877"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3877-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,4]]},"article-number":"29"}}